Seminars in Oncology
Volume 33, Issue 5 , Pages 588-595 , October 2006

Molecular Pathways in Renal Cell Carcinoma—Rationale for Targeted Treatment

  • William Y. Kim

      Affiliations

    • Department of Hematology Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
    • ,
  • William G. Kaelin Jr

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
    • Howard Hughes Medical Institute, Chevy Chase, MD, USA.
    • Corresponding Author InformationAddress correspondence to Willima G. Kaelin Jr, MD, Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00267-3

doi: 10.1053/j.seminoncol.2006.06.001

Seminars in Oncology
Volume 33, Issue 5 , Pages 588-595 , October 2006

Article Tools

* Image Usage & Resolution